Reports
Sale
Global Sacral Nerve Stimulation Market Share, Size, Analysis: By Product: Implantable SNS Devices, External SNS Devices; By Type: Electrical Muscle Stimulation, Transcutaneous Electrical Nerve Stimulation; By Application: Urinary & Fecal Incontinence, Urge Incontinence, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Sacral Nerve Stimulation Market Outlook
The value of the global sacral nerve stimulation market was USD 1,361.53 million in 2023, driven by the by increasing prevalence of urinary and faecal incontinence across the globe across the globe. The market is expected to grow at a CAGR of 12.50% during the forecast period of 2024-2032 to reach value of USD 3,930.07 million by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Segmentation
Sacral nerve stimulation is implanted as a device for controlling bladder functions by providing sacral nerves along with regulated electrical impulses that modulate the neural pathways. It is an efficient and secure therapy for patients with faecal and urinary dysfunction. The major application sectors include urinary and fecal incontinence, urge incontinence, chronic anal fissure, and others. The two types of sacral nerve stimulation are:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
- Electrical Muscle Stimulation
- Transcutaneous Electrical Nerve Stimulation
The market can be further divided on the basis of product into:
- Implantable SNS Devices
- External SNS Devices
The EMR report looks into the regional sacral nerve stimulation markets like the North America, Latin America, Europe, Middle East and Africa, and Asia Pacific.
Market Analysis
The global sacral nerve stimulation industry is being driven by increasing incidence of urge incontinence, and availability of medical reimbursements. Implantable SNS devices segment is leading the market as a result of increasing incidents of urinary incontinence, pelvic pain, and fecal incontinence, and growing number of patients suffering from UTI and urge continence. External SNS devices is expected to grow at the fastest rate owing to increased incidence of OAB and fecal incontinence. North America is leading the market due to growing awareness regarding treatment, increasing cases of OAB and urge incontinences, improvement in healthcare facilities, technological advancements in medicinal sector such as implantable SNS devices, and expanding compensations for innovations. Asia Pacific is the emerging market owing to increased cases of fecal incontinence and urinary incontinence, growing awareness programs, and presence of a large key players in economies, such as China and Japan.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
The report presents a detailed analysis of the following key players in the global sacral nerve stimulation market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Medtronic Plc
- Abbott Laboratories
- Axonics, Inc.
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s five forces.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Sacral Nerve Stimulation Market Overview
3.1 Global Sacral Nerve Stimulation Market Historical Value (2017-2023)
3.2 Global Sacral Nerve Stimulation Market Forecast Value (2024-2032)
4 Global Sacral Nerve Stimulation Market Landscape
4.1 Global Sacral Nerve Stimulation Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Sacral Nerve Stimulation Product Landscape
4.2.1 Analysis by Type of Biosensor
4.2.2 Analysis by Technology Used
4.2.3 Analysis by Applications
5 Global Sacral Nerve Stimulation Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Sacral Nerve Stimulation Market Segmentation
6.1 Global Sacral Nerve Stimulation Market by Product
6.1.1 Market Overview
6.1.2 Implantable SNS Devices
6.1.3 External SNS Devices
6.2 Global Sacral Nerve Stimulation Market by Type
6.2.1 Market Overview
6.2.2 Electrical Muscle Stimulation
6.2.3 Transcutaneous Electrical Nerve Stimulation
6.3 Global Sacral Nerve Stimulation Market by Application
6.3.1 Market Overview
6.3.2 Urinary & Fecal Incontinence
6.3.3 Urge Incontinence
6.3.4 Chronic Anal Fissure
6.3.5 Others
6.4 Global Sacral Nerve Stimulation Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Ambulatory Surgical Centres
6.4.4 Others
6.5 Global Sacral Nerve Stimulation Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Sacral Nerve Stimulation Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Sacral Nerve Stimulation Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Sacral Nerve Stimulation Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Sacral Nerve Stimulation Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Sacral Nerve Stimulation Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Medtronic
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Abbott Laboratories
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Axonics, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Boston Scientific Corporation
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 St. Jude Medical
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Cyberonics
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Neuropace
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Synapse Biomedical
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Uroplasty Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Codman And Shurtleff Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 IntraPace Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
18 Global Sacral Nerve Stimulation Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The global sacral nerve stimulation market reached a value of USD 1,361.53 million in 2023.
The market is projected to grow at a CAGR of nearly 12.50% in the forecast period of 2024-2032.
The major drivers of the industry include rising disposable incomes, increasing population, the rising availability of medical reimbursements, rising incidents of urinary incontinence, pelvic pain, and faecal incontinence, and the rising number of patients suffering from UTI.
The rising improvement in healthcare facilities, technological advancements in medicinal sector such as implantable SNS devices, and expanding compensations for innovations are expected to be the key trends guiding the growth of the industry.
North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the leading regions in the market, with North America accounting for the largest market share.
The leading products in the market are implantable SNS devices and external SNS devices.
The major types of sacral nerve stimulation in the industry are electrical muscle stimulation and transcutaneous electrical nerve stimulation.
The major application segments in the industry are urinary and faecal incontinence, urge incontinence, and chronic anal fissure, among others.
The leading players in the market are Medtronic Plc, Abbott Laboratories, Axonics, Inc., Others.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER